BeatSarcoma has funded the following projects: Ongoing research
at Stanford University Medical Center Research in the laboratory
that is run by Drs. Matt van de Rijn and Rob West in the
pathology department at Stanford University Medical Center has
focused for the past ten years on using novel technologies to
identify new diagnostic markers, prognostic markers and
potential therapeutic targets in sarcoma. The technology that we
used initially was that of gene microarrays with which we can
study the level of expression of tens of thousands mRNAs. An
mRNA is essentially a message molecule that tells the cell which
protein to make; the study of these mRNAs was revolutionized by
the invention of the gene microarray technology by Dr. Pat Brown
at Stanford University. For the first time we were able to study
in a single experiment of a level of not just one but 20,000
messenger RNAs. More recently the gene array technology has been
replaced with the so-called “high throughput sequencing” or
“next generation sequenc